CORSINI, Lidia Rita
 Distribuzione geografica
Continente #
NA - Nord America 4.176
EU - Europa 2.269
AS - Asia 1.876
SA - Sud America 341
Continente sconosciuto - Info sul continente non disponibili 240
AF - Africa 57
OC - Oceania 3
Totale 8.962
Nazione #
US - Stati Uniti d'America 4.061
SG - Singapore 738
RU - Federazione Russa 677
CN - Cina 462
IT - Italia 449
FI - Finlandia 312
BR - Brasile 258
DE - Germania 231
HK - Hong Kong 205
VN - Vietnam 154
GB - Regno Unito 112
FR - Francia 104
PL - Polonia 104
UA - Ucraina 82
CA - Canada 61
JP - Giappone 60
IN - India 48
IE - Irlanda 44
BD - Bangladesh 40
SE - Svezia 34
KR - Corea 33
RO - Romania 26
MX - Messico 25
IQ - Iraq 24
TR - Turchia 24
NL - Olanda 23
EC - Ecuador 19
BE - Belgio 18
AR - Argentina 17
AT - Austria 16
CO - Colombia 16
ZA - Sudafrica 16
VE - Venezuela 13
CI - Costa d'Avorio 11
ES - Italia 11
IR - Iran 9
MA - Marocco 9
PK - Pakistan 8
ID - Indonesia 7
AE - Emirati Arabi Uniti 6
NP - Nepal 6
PH - Filippine 6
UY - Uruguay 6
UZ - Uzbekistan 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
KZ - Kazakistan 5
PR - Porto Rico 5
AZ - Azerbaigian 4
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
KG - Kirghizistan 4
MY - Malesia 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AU - Australia 3
BO - Bolivia 3
CL - Cile 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
LT - Lituania 3
PA - Panama 3
TN - Tunisia 3
TW - Taiwan 3
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
NI - Nicaragua 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
ET - Etiopia 1
GD - Grenada 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.725
Città #
Ashburn 601
Singapore 446
Fairfield 313
San Jose 292
Chandler 279
Hong Kong 189
Woodbridge 184
Ann Arbor 153
Moscow 126
Seattle 125
Wilmington 119
Houston 116
Palermo 116
Cambridge 107
Council Bluffs 98
Los Angeles 92
Zgierz 86
Helsinki 77
Beijing 76
New York 75
Rome 65
The Dalles 65
Santa Clara 64
Dallas 59
Medford 58
Tokyo 56
Frankfurt am Main 46
Des Moines 45
Altamura 42
Dublin 42
Ho Chi Minh City 42
Lauterbourg 42
Chicago 40
Hanoi 40
Jacksonville 39
Boardman 38
Hefei 34
Princeton 34
Lawrence 32
São Paulo 32
Milan 29
Nanjing 29
San Diego 27
Dearborn 23
Orem 23
Phoenix 23
Ludwigshafen am Rhein 21
Buffalo 20
London 20
Atlanta 18
Brussels 18
Jinan 18
Bremen 15
Warsaw 15
Denver 14
Johannesburg 14
Nuremberg 14
Seoul 14
Nanchang 13
Toronto 13
Tulsa 13
Falls Church 12
Montreal 12
Stockholm 12
Abidjan 11
Changsha 11
Munich 11
Venice 11
Brasília 10
Guangzhou 10
Hebei 10
Poplar 10
Shenyang 10
Tianjin 10
Amsterdam 9
Chennai 9
Kumar 9
Mumbai 9
Ankara 8
Baghdad 8
Brooklyn 8
Columbus 8
Lappeenranta 8
Manchester 8
Turku 8
Boston 7
Da Nang 7
Kitzingen 7
Paris 7
Rio de Janeiro 7
Tappahannock 7
Bexley 6
Changzhou 6
Guayaquil 6
Haiphong 6
Izmir 6
Kilburn 6
Mexico City 6
Montevideo 6
Ottawa 6
Totale 5.307
Nome #
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 344
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 322
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 307
Breast cancer genome-wide association studies: there is strength in numbers 306
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 303
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 299
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 288
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 280
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 277
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 274
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 273
VUS variants in BRCA genes of hereditary breast/ovarian cancer 251
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 247
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 244
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 236
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 231
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 222
Gene signatures in CRC and liver metastasis 220
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 215
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 206
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 190
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 183
MUTYH-associated tumor syndrome: The other face of MAP 182
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 180
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 176
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 176
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 166
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 165
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 163
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 163
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 157
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints 155
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 150
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 149
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 142
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 141
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 139
HIF-1a induces downregulated expression of Aurora A in breast cancer cell lines 137
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 128
Scientific Communication and oncology – "The bridge between knowledge and patients" 127
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 123
Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis 117
Monoclonal antibodies for the treatment of non-hematological tumors: a safety review 114
POLE-mutated endometrial cancer: new perspectives on the horizon? 94
Totale 8.962
Categoria #
all - tutte 30.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022385 0 0 17 15 38 27 21 20 50 64 56 77
2022/2023734 75 143 16 102 83 101 29 49 78 9 33 16
2023/2024458 20 35 27 32 31 92 48 71 5 30 8 59
2024/20251.255 14 83 107 68 72 55 185 114 48 173 144 192
2025/20263.594 319 119 195 331 387 584 499 343 259 334 102 122
2026/2027503 136 83 284 0 0 0 0 0 0 0 0 0
Totale 8.962